Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	View
JYSZ2200027	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	License Renew	2022-06-29				view
JYSZ2200049	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	License Renew	2022-09-14				view
JYSB2400049	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-03-07				view
JYSB2200165	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2022-08-24		Bayer Healthcare LLC		view
JTS2400109	注射用培重组人凝血因子VIII		Lyophilized	Biological Products	Disposable Import Drug Application	2024-09-25				view
JXSS2200008	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products(3.1)	Import Drug Application	2022-01-26				view
JYSB2101160	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2021-11-10				view
CYSB2400134	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products(原10)	Supplementary Application	2024-05-24		SinoCelltech Ltd		view
JYSB2101169	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2021-11-25				view
CYSB2400294	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products(原10)	Supplementary Application	2024-11-12		SinoCelltech Ltd		view
JYSB2101028	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2021-05-12		Bayer Healthcare LLC		view
JYSB2300036	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2023-02-23		Bayer Healthcare LLC		view
JXSS2200003	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products(3.1)	Import Drug Application	2022-01-26				view
JXSS2200007	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products(3.1)	Import Drug Application	2022-01-26				view
JYSB1200216	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2012-08-27	拜耳医药保健有限公司	Bayer Healthcare Company Ltd	Approval Completed-Pending Certificated	view
JYSB2300181	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2023-10-26				view
JYSB2200144	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2022-08-08		Bayer Healthcare LLC		view
JYSB2400179	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-08-14				view
JYSZ2200048	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	License Renew	2022-09-14				view
JYSB2400051	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-03-07				view